Future Fund LLC Increases Holdings in Haleon PLC Sponsored ADR $HLN

Future Fund LLC raised its holdings in shares of Haleon PLC Sponsored ADR (NYSE:HLN) by 21.8% in the 2nd quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 58,007 shares of the company’s stock after acquiring an additional 10,382 shares during the quarter. Future Fund LLC’s holdings in Haleon were worth $602,000 as of its most recent filing with the SEC.

Several other hedge funds and other institutional investors have also made changes to their positions in HLN. Brighton Jones LLC acquired a new position in Haleon in the fourth quarter valued at approximately $187,000. Concurrent Investment Advisors LLC boosted its position in shares of Haleon by 32.9% in the 1st quarter. Concurrent Investment Advisors LLC now owns 16,363 shares of the company’s stock valued at $168,000 after purchasing an additional 4,055 shares during the period. M&T Bank Corp grew its stake in Haleon by 28.0% during the 1st quarter. M&T Bank Corp now owns 44,153 shares of the company’s stock worth $455,000 after buying an additional 9,658 shares during the last quarter. Ballentine Partners LLC grew its stake in Haleon by 9.9% during the 1st quarter. Ballentine Partners LLC now owns 29,620 shares of the company’s stock worth $305,000 after buying an additional 2,659 shares during the last quarter. Finally, Kathmere Capital Management LLC increased its position in Haleon by 40.3% during the first quarter. Kathmere Capital Management LLC now owns 66,070 shares of the company’s stock worth $680,000 after buying an additional 18,971 shares during the period. Institutional investors and hedge funds own 6.67% of the company’s stock.

Haleon Stock Up 0.7%

HLN stock opened at $9.47 on Monday. The stock has a market capitalization of $42.19 billion, a PE ratio of 24.29, a price-to-earnings-growth ratio of 2.84 and a beta of 0.20. The company has a fifty day moving average of $9.28 and a 200-day moving average of $9.92. The company has a debt-to-equity ratio of 0.48, a quick ratio of 0.63 and a current ratio of 0.87. Haleon PLC Sponsored ADR has a one year low of $8.71 and a one year high of $11.42.

Wall Street Analyst Weigh In

Several equities research analysts have recently weighed in on the company. Weiss Ratings reissued a “hold (c)” rating on shares of Haleon in a report on Wednesday, October 8th. The Goldman Sachs Group upgraded shares of Haleon from a “neutral” rating to a “buy” rating in a research note on Wednesday, September 10th. Finally, Barclays downgraded shares of Haleon from an “overweight” rating to an “equal weight” rating in a research report on Tuesday, September 16th. One investment analyst has rated the stock with a Strong Buy rating, three have issued a Buy rating and six have issued a Hold rating to the company. According to data from MarketBeat, the company has a consensus rating of “Moderate Buy” and an average price target of $12.33.

Haleon Profile

Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands.